Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations

EuroIntervention

Volumn 6, Issue 1, 2010, Pages 69-77

  Kyono, Hiroyuki ^a   Guagliumi, Giulio ^b   Sirbu, Vasile ^b   Rosenthal, Noah ^a   Tahara, Satoko ^a   Musumeci, Giuseppe ^b   Trivisonno, Antonio ^b   Bezerra, Hiram G ^a   Costa, Marco A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Bifurcation; Optical coherence tomography; Stents; Vascular response

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG; ZOTAROLIMUS; METAL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION; TREATMENT RESPONSE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; INSTRUMENTATION; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTHESIS; RADIOGRAPHY; STENT; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 77957277393     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I1A11     Document Type: Article

References (34)

1. Regar E, Serruys PW, Bode C, Holubarsch C, Guermonprez JL, Wijns W, Bartorelli A, Constantini C, Degertekin M, Tanabe K, Disco C, Wuelfert E, Morice MC; RAVEL Study Group. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation. 2002; 106:1949-56. (Pubitemid 35176300)
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315-23. (Pubitemid 37186209)
3. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003; 107:38-42. (Pubitemid 36070930)
4. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003; 108:788-94. (Pubitemid 37022118)
5. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Müzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006; 114:798-806. (Pubitemid 44268230)
6. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR Jr. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000; 35:929-36. (Pubitemid 30189924)
7. Gobeil F, Lefèvre T, Guyon P, Louvard Y, Chevalier B, Dumas P, Glatt B, Loubeyre C, Royer T, Morice MC. Stenting of bifurcation lesions using the Bestent: a prospective dual-center study. Catheter Cardiovasc Interv. 2002; 55:427-33. (Pubitemid 34263163)
8. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108-13.
9. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter PJ. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004; 109:190-5.
10. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PP, de Feyter P, van Domburg RT, Serruys PW. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005; 45:947-53. (Pubitemid 40342824)
11. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293:2126-30. (Pubitemid 40617065)
12. Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990; 66:1045-66. (Pubitemid 20126435)
13. Kimura BJ, Russo RJ, Bhargava V, McDaniel MB, Peterson KL, DeMaria AN. Atheroma morphology and distribution in proximal left anterior descending coronary artery: in vivo observations. J Am Coll Cardiol. 1996; 27:825-31. (Pubitemid 26104863)
14. Shimada Y, Courtney BK, Nakamura M, Hongo Y, Sonoda S, Hassan AH, Yock PG, Honda Y, Fitzgerald PJ. Intravascular ultrasonic analysis of atherosclerotic vessel remodeling and plaque distribution of stenotic left anterior descending coronary arterial bifurcation lesions upstream and downstream of the side branch. Am J Cardiol. 2006; 98:193-6. (Pubitemid 43975494)
15. Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv. 2008; 72:237-47.
16. Costa MA, Angiolillo DJ, Tannenbaum M, Driesman M, Chu A, Patterson J, Kuehl W, Battaglia J, Dabbons S, Shamoon F, Flieshman B, Niederman A, Bass TA; STLLR Investigators. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimuseluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol. 2008; 101:1704-11.
17. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005; 112:270-8. (Pubitemid 40982311)
18. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007; 27:1500-10. (Pubitemid 46986103)
19. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006; 48:193-202. (Pubitemid 43929240)
20. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Circulation. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007; 115:2435-41.
21. Melikian N, Airoldi F, Di Mario C. Coronary bifurcation stenting. Current techniques, outcome and possible future developments. Minerva Cardioangiol. 2004;52:365-78.
22. Boxt LM, Meyerovitz MF, Taus RH, Ganz P, Friedman PL, Levin DC. Side branch occlusion complicating percutaneous transluminal coronary angioplasty. Radiology. 1986; 161:681-3. (Pubitemid 17200417)
23. Arora RR, Raymond RE, Dimas AP, Bhadwar K, Simpfendorfer C. Side branch occlusion during coronary angioplasty: incidence, angiographic characteristics, and outcome. Cathet Cardiovasc Diagn. 1989; 18:210-2. (Pubitemid 20088547)
24. Poerner TC, Kralev S, Voelker W, Sueselbeck T, Latsch A, Pfleger S, Schumacher B, Borggrefe M, Haase KK. Natural history of small and medium-sized side branches after coronary stent implantation. Am Heart J. 2002; 143:627-35. (Pubitemid 34454695)
25. Rittersma SZ, de Winter RJ, Koch KT, Bax M, Schotborgh CE, Mulder KJ, Tijssen JG, Piek JJ. Impact of strut thickness on late luminal loss after coronary artery stent placement. Am J Cardiol. 2004; 93:477-80. (Pubitemid 38221363)
26. Ormiston JA, Currie E, Webster MW, Kay P, Ruygrok PN, Stewart JT, Padgett RC, Panther MJ. Drug-eluting stents for coronary bifurcations: insights into the crush technique. Catheter Cardiovasc Interv. 2004; 63:332-6. (Pubitemid 39491406)
27. Furukawa E, Hibi K, Kosuge M, Nakatogawa T, Toda N, Takamura T, Tsukahara K, Okuda J, Ootsuka F, Tahara Y, Sugano T, Endo T, Kimura K, Umemura S. Intravascular ultrasound predictors of side branch occlusion in bifurcation lesions after percutaneous coronary intervention. Circ J. 2005; 69:325-30. (Pubitemid 40410189)
28. Dzavik V, Kharbanda R, Ivanov J, Ing DJ, Bui S, Mackie K, Ramsamujh R, Barolet A, Schwartz L, Seidelin PH. Predictors of longterm outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. Am Heart J. 2006; 152:762-9. (Pubitemid 44396889)
29. Silva GV, Fernandes MR, Madonna R, Clubb F, Oliveira E, Jimenez-Quevedo P, Branco R, Lopez J, Angeli FS, Sanz-Ruiz R, Vaughn WK, Zheng Y, Baimbridge F, Canales J, Cardoso CO, Assad JA, Falotico R, Perin EC. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis. Catheter Cardiovasc Interv. 2009;73:801-8.
30. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary Optical Coherence Tomography: A Comprehensive Review - Clinical and Research Applications. J Am Coll Cardiol Intv 2010;3:531-539.
31. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation. 2004; 110:3430-4. (Pubitemid 39602221)
32. Hasegawa T, Ako J, Ikeno F, Waseda K, Suzuki Y, Honda Y, Fitzgerald PJ. Comparison of nonuniform strut distribution between two drug-eluting stent platforms. J Invasive Cardiol. 2007; 19:244-6. (Pubitemid 46828010)
33. Opolski MP, Pracon R, Mintz GS, Okabe T, Pregowski J, Lee SY, van der Waal EC, Kalinczuk L, Roy P, Smith KA, Torguson R, Xue Z, Satler LF, Kent KM, Pichard AD, Waksman R, Weissman NJ. Relation of drugeluting stent strut distribution to stent thrombosis in coronary arteries. Am J Cardiol. 2009; 104:343-8.
34. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005; 294:1215-23. (Pubitemid 41352109)